HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

9-PAHSA

member of the fatty acid hydroxy fatty acid class of lipids

Also Known As:

9-palmitic acid hydroxy stearic acid; palmitic-acid-9-hydroxy-stearic acid

Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Fatty Acids: 27405
  - Stearic Acids: 44
    - 9-PAHSA: 7
  - Palmitic Acids: 35
    - Palmitic Acid: 1287
      - 9-PAHSA: 7

Experts

1.	Guo, Jing-Chun: 3 articles (01/2021 - 01/2020)
2.	Guo, Qi-Lin: 3 articles (01/2021 - 01/2020)
3.	Huang, Yan-Yan: 2 articles (01/2021 - 01/2021)
4.	Jin, Hong: 2 articles (01/2021 - 01/2021)
5.	Mi, Shou-Ling: 2 articles (01/2021 - 01/2021)
6.	Wang, Jian-Tao: 2 articles (01/2021 - 01/2021)
7.	Wang, Na-Na: 2 articles (01/2021 - 01/2021)
8.	Wang, Yan-Mei: 2 articles (01/2021 - 01/2021)
9.	Yu, Zhong-Yu: 2 articles (01/2021 - 01/2021)
10.	Zhang, Qian: 2 articles (01/2021 - 01/2021)

Related Diseases

1.	Inflammation (Inflammations) 01/01/2019 - "Synthesis of chemically edited derivatives of the endogenous regulator of inflammation 9-PAHSA." 10/24/2017 - "9-PAHSA supplementation completely rescues their insulin resistance and AT inflammation. " 01/01/2021 - "9-PAHSA is a novel endogenous fatty acid, and has been reported to reduce blood glucose levels and attenuate inflammation. "
2.	Hypertrophy 01/01/2021 - "Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice." 01/01/2021 - "9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice." 01/01/2021 - "Thus, 9-PAHSA benefits DCVD in diabetic mice by ameliorating carotid vascular calcification, promoting autophagic flux and reducing myocardial hypertrophy." 01/01/2021 - "Ultrasound observed that continue administration of 9-PAHSA for 4 weeks ameliorated carotid vascular calcification, and attenuated myocardial hypertrophy and dysfunction in db/db mice. "
3.	Type 2 Diabetes Mellitus (MODY) 01/01/2021 - "The results showed that 9-PAHSA, in patients with type 2 diabetes mellitus (T2DM), was significantly lower than that in non-diabetic subjects. " 01/01/2020 - "Herein, whether the 9-PAHSA that one of the PAHSAs can attenuates DM-associated cognitive impairment in a mouse model of type 2 diabetes has been investigated. "
4.	Vascular Calcification 01/01/2021 - "Thus, 9-PAHSA benefits DCVD in diabetic mice by ameliorating carotid vascular calcification, promoting autophagic flux and reducing myocardial hypertrophy." 01/01/2021 - "Ultrasound observed that continue administration of 9-PAHSA for 4 weeks ameliorated carotid vascular calcification, and attenuated myocardial hypertrophy and dysfunction in db/db mice. "
5.	Cognitive Dysfunction 01/01/2020 - "Herein, whether the 9-PAHSA that one of the PAHSAs can attenuates DM-associated cognitive impairment in a mouse model of type 2 diabetes has been investigated. " 01/01/2020 - "In summary, we conclude that exogenous supplement of 9-PAHSA can improve DM-related cognitive impairment to some extent, and the protective effect may be associated with decreased REST/NRSF (repressor element-1 silencing transcription factor/neuron-restrictive silence factor) and upregulated BDNF expression in frontal cortex."

Related Drugs and Biologics

1.	Brain-Derived Neurotrophic Factor (BDNF)
2.	Transcription Factors (Transcription Factor)
3.	Lipids
4.	Fatty Acids (Saturated Fatty Acids)
5.	Elements
6.	Blood Glucose (Blood Sugar)